This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Its Role in the Neuroradiologic Evaluation of Neurofibromatosis, Tuberous Sclerosis, and Sturge-Weber Syndrome

Andrew P. Truhan, MD; Pauline A. Filipek, MD

Arch Dermatol. 1993;129(2):219-226.

Abstract
• Background.—
Magnetic resonance imaging (MRI) has rapidly become a major diagnostic technique, displacing computed tomography (CT) as the primary neuroimaging modality in many disorders of the central nervous system. Neuroimaging studies are valuable in the diagnosis and management of neurofibromatosis, tuberous sclerosis, and Sturge-Weber syndrome. This article reviews the technique of MRI and its role in identifying the characteristic central nervous system manifestations of these neurocutaneous syndromes.

Observations.—
MRI offers superior soft-tissue contrast without the use of ionizing radiation. It provides more detailed imaging than CT of the characteristic central nervous system lesions of neurofibromatosis, tuberous sclerosis, and Sturge-Weber syndrome. In neurofibromatosis type 1, these include optic glioma, astrocytoma, and plexiform neurofibroma, and "unidentified bright objects" that are seen only with MRI. Bilateral acoustic neuromas are the hallmark of neurofibromatosis type 2. Subependymal nodules and cortical and white matter tubers are characteristic of tuberous sclerosis. Manifestations of Sturge-Weber syndrome include leptomeningeal angiomatosis, hemiatrophy, cortical calcification, and patchy parenchymal gliosis and demyelination.

Conclusions.—
MRI, especially with gadolinium enhancement, appears to be more sensitive than CT in the detection of neurofibromatosis, tuberous sclerosis, and Sturge-Weber syndrome. MRI may be the imaging method of choice for following certain patients or screening family members.

(Arch Dermatol. 1993;129:219-226)

Author Affiliations
From the Departments of Dermatology (Dr Truhan) and Pediatric Neurology (Dr Filipek), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Footnotes
Accepted for publication June 22, 1992.

Reprint requests to Pediatric Dermatology Service, ACC 715, Massachusetts General Hospital, Boston, MA 02114 (Dr Truhan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Radiological Case of the Month
Jalou et al.
Arch Pediatr Adolesc Med 2001;155:89-90.
FULL TEXT  

Familial occipital calcifications, hemorrhagic strokes, leukoencephalopathy, dementia, and external carotid dysplasia
Iglesias et al.
Neurology 2000;55:1661-1667.
ABSTRACT | FULL TEXT  

Use of ""unidentified bright objects"" on MRI for diagnosis of neurofibromatosis 1 in children
DeBella et al.
Neurology 2000;54:1646-1651.
ABSTRACT | FULL TEXT  

Screening in Neurofibromatosis Type 1
O'Connor and Murphy
Arch Dermatol 1997;133:655-656.
ABSTRACT  

Magnetic Resonance in Dermatology
Zemtsov and Dixon
Arch Dermatol 1993;129:215-218.
ABSTRACT